click below
click below
Normal Size Small Size show me how
coagulation cascade
| Question | Answer |
|---|---|
| Tissue factor binds with what activated clotting factor | VIIa |
| VIIa/TF need what two cofactors | Ca2+ and phospholipid |
| VIIa/TF, Ca2+ and phsopholipid can combine with what two clotting factors to produce activated clotting factors | IX and XIa to make IXa or X and IXa to make Xa |
| IXa can activate what clotting factor | Xa |
| XII requires what two cofactors to become activated | High molecular weight kininogen and prekallikrein |
| XIIa uses high molecular weight kallikrein to activate what clotting factor | XIa |
| Xa converts what clotting factor to active form without requiring cofactors | VIII to VIIIa |
| Xa requires cofactors Ca2+ and phospholipid to convert what clotting factor to an active form | VII to VIIa |
| Prothrombin requires what cofactor and what activated clotting factor to produce thrombin | Phospholipid and Xa |
| What are the cofactors the clotting cascade requires in order to function | Tissue factor, Ca2+, Phospholipid, Tissue factor, high-molecular weight kininogen and prekallikrein |
| Thrombin converts what clotting factor to its active form | V to Va |
| Fibrinogen requires what to form a fibrin monomer | Thrombin |
| Fibrin polymer requires what clotting factor to form crosslinked fibrin polymer | XIIIa |
| XIII can be converted to an active form by what two methods | 1. Thrombin 2. Xa |
| The coagulation cascade is initiated by what mechanism | Tissue factor release at the site of injury |
| Tissue factor complexes with what factor at the site of injury | Factor VIIa |
| Amplification of the clotting cascade involves what factors | Thrombin: activates platelets and cofactors V and VII. VIIIa, Va, and IXa assemble on the surface of activated platelets |
| Propagation of the clot occurs via what process | The complexes on activated platelets continue the cascade and prothrombinase converts PT to thrombin which converts fibrinogen to fibrin and then clot stabilization by polymerization of fibrin monomers |